Gala Global Inc (GLAG) 0.0240 $GLAG Gala Global's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gala Global Inc (GLAG) 0.0240 $GLAG

Gala Global's Cannabis Ventures, Inc. Lands Two New Contracts
ACCESSWIRE - Tue Jul 07, 7:00AM CDT
Cannabis Pioneer Calvin Frye Join Gala Global, Inc. Advisory Board

Gala Global Introducing New Cannabidiol Products
ACCESSWIRE - Wed Jun 24, 8:25AM CDT
CBD Life Water, CBD LifeTeas, and CBD Life Vapor Pens Marketed through CBDLIVIN.COM

Charles Houghton, Esq. to Lead Gala Global Attain Hemp License and Operating Location in Colorado
ACCESSWIRE - Wed May 13, 7:15AM CDT
Legal Industry Expert on Hemp and Cannabis to Join Gala Global, Inc. Board of Directors

Gala Global, Inc. Introduces New CEO and Board Director
GlobeNewswire - Thu May 07, 7:15AM CDT
Gala Global, Inc. (OTCPK:GLAG) is pleased to announce industry expert Mr. Drew Milburn as Gala Global's new CEO. Mr. Milburn has been a leader in the Cannabis and Hemp sector with focus in Cannabidiol since 2005. Mr. Milburn has developed manufacturing plans that helped ensure the controlled and continuous production of high quality medical cannabis and hemp. Mr. Milburn also started We Grow Colorado, which was the first medical marijuana operation licensed in Colorado Springs in 2010. This new management brings over a decade of experience in evaluation, knowledge management and learning that will position Gala Global to the next level.

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part IV
Anthony Cataldo - at Seeking Alpha - Fri Apr 17, 12:54PM CDT

FULL: 3.10 (+0.01), GWPH: 87.75 (+0.45)

Gala Global Reports on Significant Progress and Plans for 2015
ACCESSWIRE - Fri Feb 13, 7:00AM CST
Gala Global Plans to Introduce Products from Paul Frank in 2nd quarter

Gala Global to Finalize Initial Hemp "CBD" Products
GlobeNewswire - Wed Feb 11, 9:56AM CST
Gala Global, Inc. (OTCQB:GLAG) today announced it has finalized the initial CBD products. The initial products will based on flavored infused CBD Oral Thin Film Strips. Gala Global's products will feature a 13 mg Flavored CBD Oral Thin Film Strip and a 25 mg Flavored CBD Oral Thin Strip that will address the dietary supplement market. The CBD products will be scientifically formulated for maximum nutritional benefits and will produced in an FDA Certified GMP facility to ensure the repeatable high quality standards. The products will be finalized and ready for market introduction upon analytical testing to be completed.

Technology Industry Leaders to Join Gala Global, Inc. Board of Directors
GlobeNewswire - Wed Jan 21, 7:01AM CST
Gala Global, Inc. (OTCQB:GLAG) today announced that internationally recognized energy entrepreneur Erlend Olson and highly accomplished Pharmaceutical, Biotechnology and Medical Device expert Russell Anderson have joined the Gala Global Board of Directors. Prior to joining Gala Global, Inc., Mr. Erlend Olson spent the first 15 years of his career as a member of technical staff at NASA's Jet Propulsion Laboratory. In the late 1990's, Mr. Olson was then the founder and CTO of Pivotal Technologies, which merged with Broadcom in a transaction valued at over $600M at closing. Mr. Olson has also been involved in raising private equity and debt capital for various private companies, and is the author/holder of 38 patents, patent applications and patents pending. Mr. Russell Anderson has held senior management positions in Product Development and Process Engineering functions for several medical device and biopharma companies including Cohesion Technologies, Novare Surgical, Artes Medical, and AscentX Medical Corporation. Mr. Anderson has also served as a principal consultant for many clients including Amgen, Astute Medical, Baxter Pharmaceuticals, Boston Scientific, Genentech, Novartis, NuVasive, Roche and Sandoz. Mr. Anderson is a named inventor on over 30 patents in the medical device and biopharmaceutical fields.
BSX: 16.88 (+0.09), AMGN: 149.59 (-0.31), NVS: 91.90 (-0.71)

Gala Global to Introduce Cannabidiol "CBD" Nutraceutical Products
Marketwired - Tue Jan 06, 7:25AM CST
Gala Global, Inc. (OTCQB: GLAG) today announced a new line of CBD infused nutraceutical products that will be introduced in the 1st quarter for 2015. Our Cannabidiol products will be scientifically formulated for maximum nutritional benefits. The CBD products will be produced in an FDA Certified GMP facility to ensure the repeatable high quality standards. The planned products to market will be completely free of and will contain no traces of THC. Products will be legal in all 50 states.

Gala Global Taps Fashion Icon Paul Frank to Create Hemp Based Products
Marketwired - Thu Dec 18, 7:45AM CST
Gala Global, Inc. (OTCQB: GLAG) today announced that internationally recognized designer and entrepreneur Paul Frank, original founder of Paul Frank Industries and creator of Julius the Monkey with the full line of animated characters, has agreed to join the company's board of directors and lead the creative direction for Gala's upcoming Hemp based fiber apparel and accessories division.

Cannabis Market Report for Friday November 14, 2014
ACCESSWIRE - Fri Nov 14, 9:55AM CST
CORAL GABLES, FL / ACCESSWIRE / November 14, 2014 / It's no secret that marijuana has taken the country by storm. Millions of dollars are traded in and out of the stock market as the marijuana space continues investors. Is it a question of "post-prohibition potential" or simply savvy traders trying to make a buck? Time will tell. But for now as more states continue to bring to the forefront new legalization efforts, this emerging market has steadily gained more attention. There have certainly been growing pains and the recent implementation of a Republican majority does have some people wondering how this will play out as we move closer to a presidential election. For the moment it appears that following the marijuana market's early autumn consolidation, marijuana stocks are beginning to regain some steam.

Gala Global, Inc. Plans for New Products and Service From Hemp and Cannabis
Marketwired - Thu Nov 06, 7:40AM CST
Gala Global, Inc. (OTCQB: GLAG) today announced expansion plans for business opportunities related to Hemp and Cannabis. The Hemp and Cannabis plant provide applications for new products and service offering from Gala Global. The new focus and direction for GALA is to stay in line with natural and eco-friendly products but allow such products to be used for multiple applications.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading